Evaluation of Cleavable (Tyr3)-octreotate Derivatives for Longer Intracellular Probe Residence
- 29 April 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 15 (3) , 647-657
- https://doi.org/10.1021/bc049972c
Abstract
Radioligand targeting of somatostatin receptor subtype 2 (sstr2)-positive tumors with synthetic somatostatin analogues such as octreotide is subject to improvement in tumor to nontumor biodistribution, in part because internalization of such somatostatin analogues is limited by sstr2 recycling to the cell surface. We reasoned that it might be possible to prepare probe-carrying somatostatin analogues that would escape recycling, efficiently depositing probe molecules inside cells and ultimately increasing their intracellular concentration. We have incorporated cathepsin-B-cleavable linkers into (Tyr3)-octreotate chelate conjugates and examined these constructs as to cellular uptake, externalization, subcellular localization, and cleavage in the rat pancreatic tumor cell line AR42J in culture. Comparison of the cleavable radioligands with a noncleavable control indicates that scission of the constituent cathepsin B substrate occurs at a rate faster than ligand externalization, depositing virtually all internalized cleaved radiochelates within lysosomal compartments.Keywords
This publication has 16 references indexed in Scilit:
- 99mTc-Demotate 1: first data in tumour patients?results of a pilot/phase I studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- 86Y-DOTA0-d-Phe1-Tyr3-octreotide (SMT487)—a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusionEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginineEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokineticsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- Differential Internalization of Somatostatin in COS-7 Cells Transfected with SST1and SST2Receptor Subtypes: A Confocal Microscopic Study Using Novel Fluorescent Somatostatin Derivatives1Endocrinology, 1997
- Lysosomal Targeting of Epidermal Growth Factor Receptors via a Kinase-dependent Pathway Is Mediated by the Receptor Carboxyl-terminal Residues 1022-1123Journal of Biological Chemistry, 1996
- Generally Applicable, Convenient Solid-Phase Synthesis and Receptor Affinities of Octreotide AnalogsJournal of Medicinal Chemistry, 1994
- Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1993
- Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomasInternational Journal of Cancer, 1991
- Conjugation of antibodies with bifunctional chelating agents: Isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ionsAnalytical Biochemistry, 1984